← Evidence map

ArticleClinicoEconomics and outcomes research : CEOR2017

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate.

Maurizio Benucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2017
2018
2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28765712